Patel Sanj K reported option exercise involving 145,763 derivative units of Kiniksa Pharmaceuticals International, plc at $0.00 for $0 on Nov 4, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CHAIRMAN & CEO
CHAIRMAN & CEO
Filed Nov 6, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
145,763Share Option
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 4, 2026Option exercise
Filed
Nov 6, 2026, 4:52 PM ET2-day reporting delay
Accession
0001532218-26-000020Code M · Transaction 395056
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Option exercise145,763$17.92$2,612,072.96Trade 395050
Nov 4, 2026Sell1,460$92.35−$134,831Trade 395051
Nov 4, 2026Sell11,335$93.54−$1,060,275.90Trade 395052
Nov 4, 2026Sell81,742$94.20−$7,700,096.40Trade 395053
Nov 4, 2026Sell29,845$95.48−$2,849,600.60Trade 395054
Nov 4, 2026Sell26,918$96.05−$2,585,473.90Trade 395055
7 transaction rows in this filing. Joint filers share the same rows.

KNSA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
KNSA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −19%1w ago +1.4%1d ago +1.4%
Returns since7d +2.6%30d90d180d1y

Footnotes in full

F1: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026. F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $91.945 and $92.655. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. F3: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $92.95 and $93.92. The price 5reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. F4: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $93.95 and $94.94. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. F5: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $94.95 and $95.94. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. F6: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $95.95 and $96.19. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. F7: The option is fully vested and exercisable.